Beyond the Reach of Drug Therapies
When we designed Sigyn TherapyTM, we envisioned the possibility of a blood purification technology that could extract pathogen sources of life-threatening inflammation and simultaneously dampen down the overproduction of inflammatory cytokines (the cytokine storm). The elevated presence of these bloodstream targets is associated with increased mortality in sepsis (leading cause of hospital deaths) and other pathogen-associated inflammatory disorders that are not addressed with drug therapies.
From a Conceptual Vision to Reality
Sigyn Therapy Highlights
- Sigyn Therapy is a single-use disposable device designed for deployment on the established infrastructure of hemodialysis and continuous renal replacement machines located in hospitals and clinics around the world.
- Sigyn Therapy has an immense capacity to extract bloodstream targets as it incorporates a formulation of adsorbent components that provide more than 200,000 square meters (~50 acres or 37 American football fields) of surface area on which to adsorb and remove bloodstream targets.
- Sigyn Therapy is also highly efficient, as a patient’s entire circulatory system can pass through the device more than 15-times during a four-hour treatment.
- Unlike devices that concentrate therapeutic targets in the blood-path, Sigyn Therapy isolates and extracts therapeutic targets from the bloodstream to eliminate continued blood cell interactions during treatment.